Status | Study |
Completed |
Study Name: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia Condition: Hemodialysis Hyperphosphatemia Date: 2013-05-07 Interventions: Drug: PA21 |
Completed |
Study Name: A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Condition: Hemodialysis Hyperphosphatemia Date: 2013-05-07 Interventions: Drug: PA21 Drug: Sevelamer hydrochloride |
Completed |
Study Name: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients Condition: Hyperphosphatemia Date: 2013-05-04 Interventions: Drug: Mg Oxide 250 mg orally for 4 weeks Other Name: |
Completed |
Study Name: A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Condition: Hemodialysis Patients With Hyperphosphatemia Date: 2013-04-12 Interventions: Drug: PA21 |
Completed |
Study Name: Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients Condition: Hemodialysis Hyperphosphatemia Cardiovascular Events Date: 2012-12-19 Interventions: Drug: Sevelamer HCl Non-metal |
Recruiting |
Study Name: A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children Condition: Hyperphosphatemia Date: 2012-09-26 Interventions: Drug: Lanthanum carbonate Subj |
Active, not recruiting |
Study Name: Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study Condition: Hemodialysis Hyperphosphatemia Date: 2012-04-13 Interventions: Drug: Lanthanum Carbonate Drug: Calcium Ca |
Completed |
Study Name: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients Condition: Hyperphosphatemia Date: 2012-01-18 Interventions: Drug: Lanthanum Carbonate (BAY77-1931) |
Completed |
Study Name: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate Condition: Hyperphosphatemia Date: 2012-01-18 Interventions: Drug: Lanthanum carbonate (BAY77-1931) Dru |
Completed |
Study Name: Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) Condition: Hyperphosphataemia ESRD Date: 2011-08-26 |